Adage Capital Partners’s Takeda Pharmaceutical TAK Stock Holding History

Adage Capital Partners’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97M	Sell	6,050,771 -374,213	-6%	-$6.19M	0.14%	143
2026 Q1	$119M	Buy	+6,424,984	New	+$113M	0.18%	106
2025 Q3	–	Sell	-2,533,725	Closed	-$39.2M	–	973
2025 Q2	$39.2M	Sell	2,533,725 -899,298	-26%	-$13.3M	0.07%	290
2025 Q1	$51M	Buy	+3,433,023	New	+$48.1M	0.09%	221
2021 Q3	–	Sell	-250,000	Closed	-$4.21M	–	1065
2021 Q2	$4.21M	Buy	+250,000	New	+$4.26M	0.01%	846
2019 Q2	–	Sell	-2,160,000	Closed	-$44M	–	760
2019 Q1	$44M	Buy	+2,160,000	New	+$43.5M	0.11%	217

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Adage Capital Partners's TAK Position: Q2 2026 in Review

Adage Capital Partners reduced its Takeda Pharmaceutical (TAK) stake by 5.8% in Q2 2026, selling an estimated $6.19M and leaving 6,050,771 shares worth $97M. The position accounts for 0.14% of the portfolio, ranked #143.

Adage Capital Partners first reported a position in TAK in Q1 2019 and has held it in 6 quarters since. The position peaked at $119M in Q1 2026. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Adage Capital Partners held 6,050,771 shares of Takeda Pharmaceutical worth $97M as of Q2 2026.
Adage Capital Partners sold 374,213 Takeda Pharmaceutical shares in Q2 2026, an estimated $6.19M.
Takeda Pharmaceutical made up 0.14% of Adage Capital Partners's portfolio in Q2 2026, its #143 holding.
Adage Capital Partners first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 6 quarters since.
Adage Capital Partners's Takeda Pharmaceutical position peaked at $119M in Q1 2026.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.